New guidelines for malignant melanoma

NewsGuard 100/100 Score

The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma - a disease with unfavorable prognosis.

Malignant melanoma is responsible for 90% of deaths from skin cancer. The incidence has increased 5-fold within the last 30 years and UV radiation is thought to be an important cause. Caucasian populations are most affected.

Claus Garbe of Tübingen University and his coauthors present the therapy of melanoma in the current edition of Deutsches Ärzteblatt International ( Dtsch Arztebl Int 2008; 105[49]: 845-51). Physicians should confirm the diagnosis by histopathology after complete surgical removal of the tumor. The German Cancer Society recommends specific treatments or therapeutic combinations, depending on the thickness of the tumor and its stage. For example, if the tumor has more than a specific thickness, it is recommended that the primary tumor should be surgically removed, together with the sentinel lymph nodes and in combination with immunotherapy. If surgical removal is not possible, radiotherapy is indicated. If there are distant metastases, physicians should perform monochemotherapy.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases